Cigna Group Quarterly Amortization of Intangible Assets in USD from Q1 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Cigna Group quarterly/annual Amortization of Intangible Assets history and growth rate from Q1 2018 to Q3 2024.
  • Cigna Group Amortization of Intangible Assets for the quarter ending September 30, 2024 was $436M, a 3.97% decline year-over-year.
  • Cigna Group Amortization of Intangible Assets for the twelve months ending September 30, 2024 was $1.73B, a 5.21% decline year-over-year.
  • Cigna Group annual Amortization of Intangible Assets for 2023 was $1.82B, a 3.04% decline from 2022.
  • Cigna Group annual Amortization of Intangible Assets for 2022 was $1.88B, a 6.11% decline from 2021.
  • Cigna Group annual Amortization of Intangible Assets for 2021 was $2B, a 0.81% increase from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.73B $436M -$18M -3.97% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $1.75B $420M -$35M -7.69% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $1.78B $423M -$36M -7.84% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $1.82B $451M -$6M -1.31% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $1.83B $454M -$6M -1.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 $1.83B $455M -$46M -9.18% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $1.88B $459M +$1M +0.22% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $1.88B $457M -$42M -8.42% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $1.92B $460M -$41M -8.18% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $1.96B $501M -$2M -0.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $1.96B $458M -$37M -7.48% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 $2B $499M +$4M +0.81% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $1.99B $501M +$8M +1.62% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $1.99B $503M +$7M +1.41% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $1.98B $495M -$3M -0.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $1.98B $495M -$240M -32.7% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 $2.22B $493M -$241M -32.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $2.46B $496M -$241M -32.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $2.7B $498M -$245M -33% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $2.95B $735M +$599M +440% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $2.35B $734M +$686M +1429% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $1.66B $737M +$713M +2971% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $951M $743M +$716M +2652% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $235M $136M Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $48M Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 $24M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $27M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.